本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ReShape Lifesciences, Inc.

2.37
-0.0500-2.07%
盘后2.450.0800+3.38%16:58 EDT
成交量:7.68万
成交额:18.34万
市值:565.47万
市盈率:-0.01
高:2.44
开:2.40
低:2.35
收:2.42
数据加载中...
2025/02/14

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/14

SEC问询函

Form CORRESP - Correspondence
2025/02/13

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/13

SEC问询函

Form CORRESP - Correspondence
2025/02/07

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/21

重要事件披露

Form 8-K - Current report
2025/01/21

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/01/15

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/15

SEC问询函

Form CORRESP - Correspondence
2024/12/27

重要事件披露

Form 8-K - Current report
2024/12/20

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/12/11

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/12/11

重要事件披露

Form 8-K - Current report
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/17

重要事件披露

Form 8-K - Current report
2024/09/26

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/24

重要事件披露

Form 8-K - Current report